Tracy E Bae, MD
Infectious Disease · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital - Oakland/Richmond. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bae’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A106393 · Current
Licensed to practise in California · since 2009 · expires 2029-01-31 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital - Oakland/RichmondOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.203, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.334, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital - Oakland/Richmond
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.203 | Worse | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.334 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2.01) · 443 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.01 (0.62 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 4,684 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.03 to 0.48) · 2,673 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.12 to 0.54) · 2,783 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.39 (0.96 to 5.81) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.32) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.44 to 3.71) · 359 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.63 (0 to 16.81) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.35 (1.31 to 9.38) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.04 (0.54 to 3.55) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0 to 1.61) · 2,133 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.562 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.715 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.876 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 974 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 55.2 · 127 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 10 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20 · 819 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 262 cases | None | Jul 2023 – Jun 2025 |
What patients said (2,982 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$2,083
Medicare paid this office $2,083 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 74 · Health risk score 2.91. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
The office billed $5,219, Medicare allowed $2,540 and paid $2,083; for 20 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 20 | 74 | 2.91 | $5,219 | $2,083 |
| 2022 | 12 | 22 | 72 | 2.57 | $3,467 | $1,354 |
| 2021 | 11 | 18 | 66 | 6.41 | $2,962 | $1,241 |
| 2017 | 12 | 16 | 67 | 2.80 | $2,787 | $788 |
| 2016 | 19 | 29 | 68 | 2.26 | $6,496 | $1,816 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,320 | $63 |
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,191 | $60 |
Drugs they prescribed that Part D paid
$144,746
Pharmacies billed $144,746 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 736) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
443 generic and 293 brand-name prescriptions · $144,746 in drug cost · 310 antibiotic prescriptions to 249 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cresemba | 21 | $105,929 | $5,044 |
| Typhim Vi | 58 | $4,930 | $85 |
| Havrix | 65 | $4,745 | $73 |
| Adacel Tdap | 70 | $3,570 | $51 |
| Twinrix | 25 | $3,025 | $121 |
See all 13 drugs
| Cresemba | 21 | $105,929 | $5,044 |
| Typhim Vi | 58 | $4,930 | $85 |
| Havrix | 65 | $4,745 | $73 |
| Adacel Tdap | 70 | $3,570 | $51 |
| Twinrix | 25 | $3,025 | $121 |
| Atovaquone-Proguanil | 86 | $2,701 | $31 |
| Azithromycin | 213 | $1,337 | $6 |
| Cefadroxil | 22 | $864 | $39 |
| Amoxicillin | 20 | $514 | $26 |
| Ipol | 13 | $468 | $36 |
| Doxycycline Monohydrate | 11 | $353 | $32 |
| Doxycycline Hyclate | 15 | $347 | $23 |
| Acetazolamide | 18 | $140 | $8 |
Year by year
| 2024 | 736 | 323 | 0% (0) | 40% | $144,746 |
| 2023 | 630 | 321 | 0% (0) | 26% | $119,850 |
| 2022 | 390 | 183 | 0% (0) | 25% | $98,782 |
| 2021 | 143 | 46 | 0% (0) | 11% | $100,053 |
| 2020 | 123 | 37 | 0% (0) | 19% | $72,048 |
| 2019 | 170 | 63 | 0% (0) | 15% | $33,660 |
| 2018 | 153 | 74 | 0% (0) | 22% | $30,222 |
| 2017 | 219 | 83 | 0% (0) | 22% | $38,412 |
| 2016 | 407 | 193 | 0% (0) | 35% | $64,251 |
| 2015 | 348 | 145 | 0% (0) | 22% | $88,838 |
| 2014 | 266 | 108 | 0% (0) | 12% | $71,387 |
| 2013 | 293 | 137 | None | 15% | $54,075 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Cresemba | 14 | $81,633 | $5,831 |
| Typhim Vi | 60 | $7,350 | $123 |
| Atovaquone-Proguanil | 100 | $6,263 | $63 |
| Twinrix | 23 | $2,671 | $116 |
| Havrix | 32 | $2,448 | $77 |
| Azithromycin | 244 | $1,585 | $6 |
| Doxycycline Monohydrate | 19 | $1,164 | $61 |
| Amoxicillin | 15 | $310 | $21 |
| Acetazolamide | 13 | $101 | $8 |
2022: 7 drugs
| Atovaquone-Proguanil | 60 | $6,151 | $103 |
| Typhim Vi | 34 | $4,012 | $118 |
| Havrix | 21 | $1,575 | $75 |
| Doxycycline Monohydrate | 23 | $785 | $34 |
| Azithromycin | 117 | $781 | $7 |
| Amoxicillin | 20 | $415 | $21 |
| Ipol | 11 | $374 | $34 |
2021: 3 drugs
| Doxycycline Monohydrate | 24 | $715 | $30 |
| Fluconazole | 18 | $711 | $39 |
| Amoxicillin | 34 | $700 | $21 |
2020: 4 drugs
| Cefpodoxime Proxetil | 14 | $1,893 | $135 |
| Fluconazole | 14 | $908 | $65 |
| Doxycycline Monohydrate | 17 | $616 | $36 |
| Azithromycin | 19 | $421 | $22 |
2019: 5 drugs
| Doxycycline Monohydrate | 27 | $1,014 | $38 |
| Fluconazole | 15 | $898 | $60 |
| Cefadroxil | 20 | $853 | $43 |
| Amoxicillin | 12 | $255 | $21 |
| Azithromycin | 13 | $95 | $7 |
2018: 3 drugs
| Atovaquone-Proguanil | 14 | $1,007 | $72 |
| Azithromycin | 38 | $387 | $10 |
| Amoxicillin | 13 | $347 | $27 |
2017: 7 drugs
| Voriconazole | 12 | $12,060 | $1,005 |
| Cefadroxil | 18 | $1,307 | $73 |
| Atovaquone-Proguanil | 18 | $1,216 | $68 |
| Ethambutol | 12 | $1,213 | $101 |
| Doxycycline Monohydrate | 16 | $1,020 | $64 |
| Amoxicillin | 21 | $865 | $41 |
| Azithromycin | 40 | $343 | $9 |
2016: 10 drugs
| Voriconazole | 13 | $16,969 | $1,305 |
| Atovaquone-Proguanil | 43 | $3,468 | $81 |
| Typhim Vi | 34 | $2,584 | $76 |
| Twinrix | 24 | $1,824 | $76 |
| Havrix | 34 | $1,760 | $52 |
| Doxycycline Monohydrate | 21 | $1,514 | $72 |
| Azithromycin | 118 | $1,139 | $10 |
| Cefadroxil | 13 | $996 | $77 |
| Amoxicillin | 12 | $727 | $61 |
| Acetazolamide | 12 | $517 | $43 |
2015: 10 drugs
| Voriconazole | 22 | $45,661 | $2,075 |
| Atovaquone-Proguanil | 36 | $4,443 | $123 |
| Cefadroxil | 28 | $1,533 | $55 |
| Typhim Vi | 19 | $1,368 | $72 |
| Doxycycline Monohydrate | 17 | $1,038 | $61 |
| Azithromycin | 77 | $850 | $11 |
| Havrix | 16 | $832 | $52 |
| Ciprofloxacin | 20 | $657 | $33 |
| Amoxicillin | 15 | $453 | $30 |
| Acetazolamide | 12 | $360 | $30 |
2014: 8 drugs
| Voriconazole | 22 | $40,908 | $1,859 |
| Atovaquone-Proguanil | 38 | $5,185 | $136 |
| Doxycycline Monohydrate | 18 | $1,011 | $56 |
| Cefadroxil | 24 | $934 | $39 |
| Amox Tr-Potassium Clavulanate | 13 | $629 | $48 |
| Amoxicillin | 17 | $505 | $30 |
| Ciprofloxacin | 42 | $466 | $11 |
| Azithromycin | 33 | $404 | $12 |
2013: 5 drugs
| Atovaquone-Proguanil | 47 | $7,039 | $150 |
| Azithromycin | 54 | $1,141 | $21 |
| Doxycycline Hyclate | 12 | $604 | $50 |
| Ciprofloxacin | 61 | $596 | $10 |
| Amoxicillin | 16 | $461 | $29 |
Money from drug and device companies
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| SANOFI PASTEUR INC. · Sta00011 Stamaril Yellow Fever · 2019 | Their institution | $181,585 |
| SANOFI PASTEUR INC. · Sta00011 Stamaril Yellow Fever · 2020 | Their institution | $143,060 |
| SANOFI PASTEUR INC. · Stamaril Yellow Fever · 2021 | Their institution | $34,270 |
Professional record
- NPI
- 1437311560
- Licence
- CA A106393California A106393: Current · expires 2029-01-31
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2007
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 275 W Macarthur Blvd, Oakland, CA, 94611
- NPI first listed
- 2008-06-30
- NPI last updated
- 2022-01-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.